Yonekura Y - Search Results

1

Acquisition of resistance to antitumor alkylating agent ACNU: a possible target of positron emission tomography monitoring.

Kawai H, Toyohara J, Kado H, Nakagawa T, Takamatsu S, Furukawa T, Yonekura Y, Kubota T, Fujibayashi Y. Kawai H, et al. Among authors: yonekura y. Nucl Med Biol. 2006 Jan;33(1):29-35. doi: 10.1016/j.nucmedbio.2005.10.002. Nucl Med Biol. 2006. PMID: 16459256

2

Basis of FLT as a cell proliferation marker: comparative uptake studies with [3H]thymidine and [3H]arabinothymidine, and cell-analysis in 22 asynchronously growing tumor cell lines.

Toyohara J, Waki A, Takamatsu S, Yonekura Y, Magata Y, Fujibayashi Y. Toyohara J, et al. Among authors: yonekura y. Nucl Med Biol. 2002 Apr;29(3):281-7. doi: 10.1016/s0969-8051(02)00286-x. Nucl Med Biol. 2002. PMID: 11929696

3

Intra-tumoral distribution of (64)Cu-ATSM: a comparison study with FDG.

Obata A, Yoshimoto M, Kasamatsu S, Naiki H, Takamatsu S, Kashikura K, Furukawa T, Lewis JS, Welch MJ, Saji H, Yonekura Y, Fujibayashi Y. Obata A, et al. Among authors: yonekura y. Nucl Med Biol. 2003 Jul;30(5):529-34. doi: 10.1016/s0969-8051(03)00047-7. Nucl Med Biol. 2003. PMID: 12831991

4

Radiolabeled choline as a proliferation marker: comparison with radiolabeled acetate.

Yoshimoto M, Waki A, Obata A, Furukawa T, Yonekura Y, Fujibayashi Y. Yoshimoto M, et al. Among authors: yonekura y. Nucl Med Biol. 2004 Oct;31(7):859-65. doi: 10.1016/j.nucmedbio.2004.05.002. Nucl Med Biol. 2004. PMID: 15464387

5

Basic characterization of 64Cu-ATSM as a radiotherapy agent.

Obata A, Kasamatsu S, Lewis JS, Furukawa T, Takamatsu S, Toyohara J, Asai T, Welch MJ, Adams SG, Saji H, Yonekura Y, Fujibayashi Y. Obata A, et al. Among authors: yonekura y. Nucl Med Biol. 2005 Jan;32(1):21-8. doi: 10.1016/j.nucmedbio.2004.08.012. Nucl Med Biol. 2005. PMID: 15691658

6

Noninvasive imaging of transplanted living functional cells transfected with a reporter estrogen receptor gene.

Takamatsu S, Furukawa T, Mori T, Yonekura Y, Fujibayashi Y. Takamatsu S, et al. Among authors: yonekura y. Nucl Med Biol. 2005 Nov;32(8):821-9. doi: 10.1016/j.nucmedbio.2005.06.010. Nucl Med Biol. 2005. PMID: 16253806

7

Double-tracer autoradiography with Cu-ATSM/FDG and immunohistochemical interpretation in four different mouse implanted tumor models.

Tanaka T, Furukawa T, Fujieda S, Kasamatsu S, Yonekura Y, Fujibayashi Y. Tanaka T, et al. Among authors: yonekura y. Nucl Med Biol. 2006 Aug;33(6):743-50. doi: 10.1016/j.nucmedbio.2006.05.005. Epub 2006 Jul 18. Nucl Med Biol. 2006. PMID: 16934693

8

Acute effects of stereotactic radiosurgery on the kinetics of glucose metabolism in metastatic brain tumors: FDG PET study.

Yamamoto T, Nishizawa S, Maruyama I, Yoshida M, Tsuchida T, Waki A, Fujibayashi Y, Kubota T, Yonekura Y, Itoh H. Yamamoto T, et al. Among authors: yonekura y. Ann Nucl Med. 2001 Apr;15(2):103-9. doi: 10.1007/BF02988599. Ann Nucl Med. 2001. PMID: 11448067

9

Hypoxic tolerance induction in rat brain slices following 3-nitropropionic acid pretreatment as revealed by dynamic changes in glucose metabolism.

Maruoka N, Murata T, Omata N, Fujibayashi Y, Yonekura Y, Wada Y. Maruoka N, et al. Among authors: yonekura y. Neurosci Lett. 2002 Feb 15;319(2):83-6. doi: 10.1016/s0304-3940(01)02542-3. Neurosci Lett. 2002. PMID: 11825676

10

Whole-body PET with FDG is useful for following up an ovarian cancer patient with only rising CA-125 levels within the normal range.

Kurokawa T, Yoshida Y, Kawahara K, Tsuchida T, Fujibayashi Y, Yonekura Y, Kotsuji F. Kurokawa T, et al. Among authors: yonekura y. Ann Nucl Med. 2002 Nov;16(7):491-3. doi: 10.1007/BF02988649. Ann Nucl Med. 2002. PMID: 12508842

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

671 results

Search Page

Filters